Literature DB >> 23960954

Mitochondrial DNA abnormalities in ophthalmological disease.

Grainne S Gorman1, Robert W Taylor.   

Abstract

Mitochondrial disorders are a group of clinically heterogeneous diseases, commonly defined by lack of cellular energy due to genetic defects of oxidative phosphorylation (OXPHOS). Ocular involvement is a prominent clinical feature of mitochondrial disease. This can manifest as optic nerve dysfunction specifically involving retinal ganglion cells as typified by Leber hereditary optic neuropathy (LHON), or progressive external ophthalmoplegia (PEO) and ptosis involving the extraocular muscles which is commonly associated with either primary mitochondrial DNA (mtDNA) mutations or acquired mtDNA defects secondary to a nuclear genetic disorder of mtDNA maintenance. In this short review, we will outline the unique characteristics of mitochondrial genetic disease and its investigation with reference to the clinical features and molecular genetic abnormalities underlying mitochondrial ophthalmological disease.

Entities:  

Keywords:  Extraocular muscle; LHON; Mitochondrial disease; Optic atrophy; Progressive external ophthalmoplegia; Retinopathy; mtDNA

Year:  2011        PMID: 23960954      PMCID: PMC3729573          DOI: 10.1016/j.sjopt.2011.02.002

Source DB:  PubMed          Journal:  Saudi J Ophthalmol        ISSN: 1319-4534


  52 in total

1.  Retinopathy of NARP syndrome.

Authors:  J B Kerrison; V Biousse; N J Newman
Journal:  Arch Ophthalmol       Date:  2000-02

2.  Sensory ataxic neuropathy as the presenting feature of a novel mitochondrial disease.

Authors:  R Fadic; J A Russell; V V Vedanarayanan; M Lehar; R W Kuncl; D R Johns
Journal:  Neurology       Date:  1997-07       Impact factor: 9.910

3.  A novel heteroplasmic tRNAleu(CUN) mtDNA point mutation in a sporadic patient with mitochondrial encephalomyopathy segregates rapidly in skeletal muscle and suggests an approach to therapy.

Authors:  K Fu; R Hartlen; T Johns; A Genge; G Karpati; E A Shoubridge
Journal:  Hum Mol Genet       Date:  1996-11       Impact factor: 6.150

4.  A heterozygous truncating mutation in RRM2B causes autosomal-dominant progressive external ophthalmoplegia with multiple mtDNA deletions.

Authors:  Henna Tyynismaa; Emil Ylikallio; Mehul Patel; Maria J Molnar; Ronald G Haller; Anu Suomalainen
Journal:  Am J Hum Genet       Date:  2009-08-06       Impact factor: 11.025

5.  A novel mitochondrial DNA point mutation in the tRNA(Ile) gene: studies in a patient presenting with chronic progressive external ophthalmoplegia and multiple sclerosis.

Authors:  R W Taylor; P F Chinnery; M J Bates; M J Jackson; M A Johnson; R M Andrews; D M Turnbull
Journal:  Biochem Biophys Res Commun       Date:  1998-02-04       Impact factor: 3.575

6.  Macular pattern dystrophy in MIDD: long-term follow-up.

Authors:  C Ambonville; T Meas; A Lecleire-Collet; M Laloi-Michelin; M Virally; J-P Kevorkian; M Paques; P Massin; P-J Guillausseau
Journal:  Diabetes Metab       Date:  2008-06-30       Impact factor: 6.041

7.  Kearns-Sayre syndrome in twins: lethal dominant mutation or acquired disease?

Authors:  L P Rowland; I Hausmanowa-Petrusewicz; B Bardurska; D Warburton; I Nibroj-Dobosz; S DiMauro; M Pallai; W G Johnson
Journal:  Neurology       Date:  1988-09       Impact factor: 9.910

8.  Mitochondrial DNA defects and selective extraocular muscle involvement in CPEO.

Authors:  Laura C Greaves; Patrick Yu-Wai-Man; Emma L Blakely; Kim J Krishnan; Nina E Beadle; Jamie Kerin; Martin J Barron; Philip G Griffiths; Alison J Dickinson; Douglass M Turnbull; Robert W Taylor
Journal:  Invest Ophthalmol Vis Sci       Date:  2010-02-17       Impact factor: 4.799

9.  A novel mitochondrial tRNAGlu (MTTE) gene mutation causing chronic progressive external ophthalmoplegia at low levels of heteroplasmy in muscle.

Authors:  Charlotte L Alston; James Lowe; Douglass M Turnbull; Paul Maddison; Robert W Taylor
Journal:  J Neurol Sci       Date:  2010-11-15       Impact factor: 3.181

10.  OPA1 mutations induce mitochondrial DNA instability and optic atrophy 'plus' phenotypes.

Authors:  Patrizia Amati-Bonneau; Maria Lucia Valentino; Pascal Reynier; Maria Esther Gallardo; Belén Bornstein; Anne Boissière; Yolanda Campos; Henry Rivera; Jesús González de la Aleja; Rosanna Carroccia; Luisa Iommarini; Pierre Labauge; Dominique Figarella-Branger; Pascale Marcorelles; Alain Furby; Katell Beauvais; Franck Letournel; Rocco Liguori; Chiara La Morgia; Pasquale Montagna; Maria Liguori; Claudia Zanna; Michela Rugolo; Andrea Cossarizza; Bernd Wissinger; Christophe Verny; Robert Schwarzenbacher; Miguel Angel Martín; Joaquín Arenas; Carmen Ayuso; Rafael Garesse; Guy Lenaers; Dominique Bonneau; Valerio Carelli
Journal:  Brain       Date:  2007-12-24       Impact factor: 13.501

View more
  1 in total

1.  Thiamine deficiency induces oxidative stress in brain mitochondria of Mus musculus.

Authors:  Anupama Sharma; Renu Bist; Parvesh Bubber
Journal:  J Physiol Biochem       Date:  2013-02-17       Impact factor: 4.158

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.